Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 1/20 | 0.46 |
| ▸ | CYSLTR2 | Q9NS75 | 2/20 | 0.44 |
| ▸ | CYSLTR1 | Q9Y271 | 2/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | PPARA | Q07869 | 2/20 | 0.41 |
| ▸ | FAAH | O00519 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | NR1H4 | Q96RI1 | 2/20 | 0.36 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.36 |
| ▸ | SOAT2 | O75908 | 1/20 | 0.35 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.35 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3659366 | 1.00 | APP (0.46) | APPCYSLTR2CYSLTR1THRBPPARA | |
| SCHEMBL3663177 | 0.96 | CYSLTR2 (0.48) | APPCYSLTR2CYSLTR1THRBPPARA | |
| SCHEMBL3764501 | 0.96 | CYSLTR2 (0.48) | APPCYSLTR2CYSLTR1THRBPPARA | |
| SCHEMBL3654739 | 0.91 | APP (0.48) | APPCYSLTR2CYSLTR1THRBPPARA | |
| SCHEMBL3771342 | 0.91 | APP (0.48) | APPCYSLTR2CYSLTR1THRBPPARA | |
| SCHEMBL3764362 | 0.89 | THRB (0.48) | APPTHRBPPARAFAAHTSHR | |
| SCHEMBL3658254 | 0.89 | THRB (0.48) | APPTHRBPPARAFAAHTSHR | |
| SCHEMBL17138154 | 0.86 | CYSLTR2 (0.50) | CYSLTR2CYSLTR1PPARAFAAHTSHR | |
| SCHEMBL17138155 | 0.86 | CYSLTR2 (0.50) | CYSLTR2CYSLTR1PPARAFAAHTSHR | |
| SCHEMBL3769189 | 0.85 | APP (0.50) | APPTHRBKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100311790-A1 | AMIDE COMPOUNDS AND PLANT DISEASE CONTROLLING METHOD USING SAME | SUMITOMO CHIEMCAL COMPANY LIMITED (JP) | 2010-12-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100311790-A1 | AMIDE COMPOUNDS AND PLANT DISEASE CONTROLLING METHOD USING SAME | ATL3, NAT1, C5 | APP 2380/4885CYSLTR2 2358/4885CYSLTR1 2654/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.